This Summit is focused on Cancer Immunotherapy, the most promising new cancer treatment approach since the development of the first chemotherapies. This summit brings together leading industry professionals in order to expand the scientific horizons of Cancer Immunotherapy, and discuss the latest advances and improvements in research and development.
We will discuss key findings, including critical insights, as well as recommendations for accelerating development in the field.
Key Practical Learning Points of the Summit:
Who Should Attend:
Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Scientists, Investigators and Managers specialising in:
Dr. Ivan Diaz-Padilla, MD Global Clinical Leader Oncology Clinical Development Novartis Pharma AG, Switzerland
Dr. Saso Cemerski Principal Scientist Merck Research Labs, USA
Dr. Robert Jabulowsky Senior Project Manager BioNTech AG
Dr. Maria Groves Associate Director, Lab Head Cancer Research UK (CRUK) – MedImmune Alliance, UK
Dr. Matthias Miller Project Manager BioNTech AG
Dr. Rer. Nat. Jennifer Altomonte Principle Investigator Department of Internal Medicine II, Germany Technical University of Munich, Germany
Dr. Armin Sepp Associate Fellow / Scientific Leader Systems Modeling & Translational Biology Computational & Modeling Sciences GSK, UK
Anja Urbank Associate Director PAREXEL, Germany
Please, complete details below:
Please, complete details below and you will get Agenda via E-mail:
Please, complete details below and you will get 500 € Document Package: